On March 29, 2022, Quentin S. Blackford notified Axogen, Inc. (the Company) of his decision to resign as a member of the Company's Board of Directors (the Board), including as a member of the Audit Committee and Compensation Committee, effective as of 11:59 PM EST on March 30, 2022. Mr. Blackford's decision to resign was not associated with or attributable to any dispute or disagreement with the Company, its management or the Board on any matter relating to the Company's operations, policies or practices, or otherwise. To fill the vacancies on the Board committees created by Mr. Blackford's departure, the Board has, in each case, effective as of March 30, 2022 (i) appointed John H. Johnson to serve on the Audit Committee as its chair, and (ii) appointed Alan M. Levine to serve on the Compensation Committee.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.375 USD | -1.67% |
|
+9.25% | +8.93% |
24/06 | Axogen, Inc. Announces Full Launch of Avive+ Soft Tissue Matrix | CI |
28/05 | Axogen, Inc. Announces the Opening of its Axogen Processing Center | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.93% | 33Cr | |
+4.58% | 21TCr | |
+9.08% | 19TCr | |
+31.71% | 16TCr | |
+32.95% | 11TCr | |
+4.45% | 6.49TCr | |
+22.11% | 5.52TCr | |
+1.51% | 4.91TCr | |
-5.02% | 3.88TCr | |
+1.40% | 3.56TCr |
- Stock Market
- Equities
- AXGN Stock
- News AxoGen, Inc.
- AxoGen, Inc. Announces Board Changes